Top Abstract Purchase Related
Home
>
Node
>
Subnode

Studies on the correct quantitative relations of antigen components in mono-, bi- and trivalent foot-and-mouth disease vaccine preparations

Sólyom, F.; Czelleng, F.

Developments in Biological Standardization 35: 289-294

1976

ISSN/ISBN: 0301-5149
PMID: 198297
Document Number: 105675
Waldmann and frenkel type mono-, bi- and trivalent FMD vaccines, with different quantitative relations of the antigen components, were prepared and tested by the E, K and S index methods. Potency tests in adult mice showed that the antigen components of the bivalent vaccines are usually synergistic, but a 47-57% excess of antigen "O1" over the other two types is always required for a similar immunogenic action (E index value). For the same reason, the "O1" content of the trivalent vaccine should be as high as the total quantity of its other two components. Trivalent FMD vaccines in which the quantitative relations of the antigen components correspond with the proportions assessed as optimal in the mouse test prove also to be satisfactorily immunogenic in cattle in respect of all three components.

Document emailed within 1 workday
Secure & encrypted payments

Giraud, M.; Loquerie, R.; Colson, X.; Guerche, J.; Durand, M.; Prunet, P. 1972: Trivalent vaccine against foot-and-mouth disease of swine. Industrial and zootechnical aspect Bulletin - Office International des Epizooties 77(5): 839-858
Kihm, U. 1976: Comparison of a bivalent anti-foot-and-mouth disease vaccine with oil adjuvant to a vaccine with DEAE-dextran adjuvant in swine Developments in Biological Standardization 35: 149-153
Zheng, Y.M.; Chang, Z.R.; Jiang, L.L.; Ji, H.; Chen, G.P.; Luo, P.; Pan, J.J.; Tian, X.L.; Wei, L.L.; Huo, D.; Miao, Z.P.; Zou, X.N.; Chen, J.H.; Liao, Q.H. 2017: Severe cases with hand, foot and mouth disease: data based on national pilot hand, foot and mouth disease surveillance system Zhonghua Liu Xing Bing Xue Za Zhi 38(6): 759-762
Tekerlekov, P.; Mitev, G.; Antov, A.; Gergov, P. 1976: Study of the immunity in swine vaccinated with type C anti-foot-and-mouth disease vaccine Veterinarno-Meditsinski Nauki 13(8): 56-61
Hantschel, H.; Wagner, S. 1970: The effect of DEAE-dextran on the infectiousness of ribonucleic acid preparations of foot-and-mouth disease virus in various host systems Archiv für Experimentelle Veterinarmedizin 24(2): 473-480
Brake, D.A.; McIlhaney, M.; Miller, T.; Christianson, K.; Keene, A.; Lohnas, G.; Purcell, C.; Neilan, J.; Schutta, C.; Barrera, J.; Burrage, T.; Brough, D.E.; Butman, B.T. 2012: Human adenovirus-vectored foot-and-mouth disease vaccines: establishment of a vaccine product profile through in vitro testing Developments in Biologicals 134: 123-133
Fivaz, B.H.; Blackburn, N.K. 1990: Infestation of cattle by the brown ear tick, Rhipicephalus appendiculatus, does not affect serological responses to foot-and-mouth disease vaccine Research in Veterinary Science 49(1): 113
Chen, C.; Xie, H.; Cui, M.; Zhen, R.; Zhang, Y.; Ni, L.; Huang, Y.; Geng, J.; Lu, H.; Di, B.; Wang, M. 2014: An investigation on a case of hand-foot-mouth disease caused by coxsackie-virus A6 associated with a vaccine-derived poliovirus co-infection Zhonghua Liu Xing Bing Xue Za Zhi 35(1): 61-65
Solisch, P.; Nöckler, A.; Schäfer, D.; Riebe, R.; Holl, U.; Schirrmeier, H.; Kretzschmar, C.; Wazel, W.; Dietz, G.; Sulk, J. 1986: A hitherto unknown reaction pattern in vertebrate cells (RiV). 2. The protective effect of RiV particle preparations against foot-and-mouth disease in guinea pigs Zentralblatt für Allgemeine Pathologie U. Pathologische Anatomie 131(6): 563-568
Lowes, E. 1972: Epidemiological studies of foot-and-mouth disease in Great Britain Bulletin - Office International des Epizooties 77(3): 481-486
Traub, E.; Moehlmann, H. 1946: Studies on immunological variants of types A and B of the foot and mouth disease virus Berliner und Münchener Tierärztliche Wochenschrift 12(1): 1-5
Nekrasova, O.V.; Boĭchenko, V.E.; Boldyreva, E.F.; Borisova, G.P.; Pumpen, P.; Perevozchikova, N.A.; Korobko, V.G. 1997: Bacterial synthesis of immunogenic epitopes of foot-and-mouth disease virus fused either to human necrosis factor or to hepatitis B core antigen Bioorganicheskaia Khimiia 23(2): 118-126
Wiśniewski, J.; Kobusiewicz, T.; Szkilnik, S.; Baranowski, C.; Jankowska, J.; Labecka, W. 1974: Quantitative assay of the immunizing dose of monovalent vaccines against foot-and-mouth disease prepared from the virus propagated on cattle tongue mucosa and in culture after Frenkel Acta Microbiologica Polonica. Series A: Microbiologia Generalis 6(1): 131
Sarateanu, D.; Ehrengut, W.; Pressler, K. 1977: Serological response to an adsorbed killed trivalent influenza vaccine (including A/New Jersey 8/76 antigen) Developments in Biological Standardization 39: 235-238
Bauer, K.; Kaaden, O.R.; Mussgay, M. 1970: Experimental studies on delayed hypersensitivity following protective inoculation of cattle against foot and mouth disease Berliner und Munchener Tierarztliche Wochenschrift 83(15): 292-298
Vasantha, S.; Antony, A.; Lal, S.M. 1986: Comparative studies on growth of foot-and-mouth disease virus types 0 and Asia 1 in BHK-21 Razi cells Acta Virologica 30(5): 367-372
Muntiu, N.; Dumitrescu, A.; Dohotaru, V.; Negrutiu, T.; Bercan, A.; Mircescu, G.; Stirbu, C.; Tomescu, A. 1972: Duration of post-vaccination immunity against foot-and-mouth disease in relation to animal age, vaccine dose and vaccination repetition (recurrence effect) Bulletin - Office International des Epizooties 77(5): 771-787
Nöckler, A.; Thalmann, G.; Haack, P.; Nehmzow, P.; Poewe, R.; Pietzsch, E.; Seils, G. 1990: Riems foot-and-mouth disease oil emulsion vaccines for swine. 2. use of foot-and-mouth 2-component oil emulsion vaccines in practice Archiv für Experimentelle Veterinarmedizin 44(2): 183-188
Mahapatra, M.; Upadhyaya, S.; Aviso, S.; Babu, A.; Hutchings, G.; Parida, S. 2017: Selection of vaccine strains for serotype O foot-and-mouth disease viruses (2007-2012) circulating in Southeast Asia, East Asia and Far East Vaccine 35(51): 7147-7153
Hahn, H.L.; Mössner, J. 1980: Influenza vaccination of risk patients with trivalent split virus vaccine and subunit vaccine Münchener Medizinische Wochenschrift 122(42): 1477-1480